Synthesis and preliminary anticancer evaluation of 10-hydroxycamptothecin analogs
Biological and Pharmaceutical Bulletin, ISSN: 0918-6158, Vol: 35, Issue: 8, Page: 1295-1299
2012
- 1Citations
- 6Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations1
- Citation Indexes1
- CrossRef1
- Captures6
- Readers6
Article Description
We have synthesized new 10-hydroxycamptothecin (HCPT) analogs and evaluated their anticancer activity in cell culture and in experimental animal tumor model. Although the new analogs were less potent against L1210 leukemia cells in vitro, some of them were more efficacious against L1210 leukemia in vivo compared to the parent HCPT. © 2012 The Pharmaceutical Society of Japan.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84864944341&origin=inward; http://dx.doi.org/10.1248/bpb.b12-00145; http://www.ncbi.nlm.nih.gov/pubmed/22863928; https://www.jstage.jst.go.jp/article/bpb/35/8/35_b12-00145/_article; https://www.jstage.jst.go.jp/article/bpb/35/8/35_b12-00145/_article/-char/en/; https://www.jstage.jst.go.jp/article/bpb/35/8/35_b12-00145/_article/-char/ja/; https://dx.doi.org/10.1248/bpb.b12-00145
Pharmaceutical Society of Japan
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know